Editorial: Genomics has more to reveal
2024-07-02
(Press-News.org)
“If there was any doubt, this discovery demonstrates that genomics, extensively deployed over the past two decades, still has much to reveal to us.”
BUFFALO, NY- July 2, 2024 – A new editorial paper was published in Oncotarget's Volume 15 on June 20, 2024, entitled, “Genomics has more to reveal.”
In this new editorial, researchers Laurène Fenwarth and Nicolas Duployez from the University of Lille and CHU Lille discuss molecular and cytogenetic analyses that are now used to identify mutations and structural variants defining distinct subtypes of acute myeloid leukemias (AML) and myelodysplastic syndromes (MDS). These genetic considerations have become essential for risk stratification and the selection of appropriate treatments, including the use of allogeneic hematopoietic stem cell transplantation.
“Despite over 15 years of genomic research since the first publication of the AML genome and large studies like The Cancer Genome Atlas (TCGA) [2], around 15% of AML cases remained genetically unclassifiable with current knowledge.”
Notably, several studies in both adults and children identified a subset of AML without known initiating events but particularly enriched in FLT3- ITD and WT1 mutations, and normal karyotypes with an overall unfavorable prognosis. In 2021–2022, notably thanks to advancements in bioinformatic approaches and tools, recurrent somatic tandem duplications (TD) of a portion of the UBTF gene were identified in high-risk pediatric AML cases.
“With increased screenings of retrospective cohorts, the characteristics associated with this molecular alteration have since been confirmed. UBTF-TD are considered initiating events in leukemogenesis and define a distinct entity of myeloid malignancies.”
Continue reading: DOI: https://doi.org/10.18632/oncotarget.28596
Correspondence to: Nicolas Duployez
Email: nicolas.duployez@chu-lille.fr
Keywords: acute myeloid leukemia, genomics, UBTF
Click here to sign up for free Altmetric alerts about this article.
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
X, formerly Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Reddit
Spotify, and available wherever you listen to podcasts
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Street., Suite 1
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-07-02
The incidence of low birth weight rose sharply in India amid the COVID-19 pandemic, according to new research from the University of Notre Dame.
Globally, 1 in 4 newborns has a low birth weight (less than 5.5 pounds), and the problem disproportionately affects low- and middle-income countries — particularly in South Asia, home to approximately one-fourth of the world’s population.
Santosh Kumar, associate professor of development and global health economics at Notre Dame’s Keough School of Global Affairs, co-authored the study published in Communications Medicine, a Nature series journal.
“This research shows that low birth weight became more common in India ...
2024-07-02
With a $300,000 grant, the Welch Foundation is supporting University of Texas at Arlington research into creating new materials to safely and effectively deliver medications to treat diseases such as cancer.
Since its founding in 1954, the Houston-based Welch Foundation has contributed over $1.1 billion to the advancement of chemistry through research grants, departmental programs, endowed chairs and other special projects in Texas.
“As one of the nation’s largest private funding sources for chemical research, we are committed to supporting the field in a way that advances science while ...
2024-07-02
A common infection-causing bacteria was much less likely to evolve antibiotic resistance when treated with a mixture of antimicrobial peptides rather than a single peptide, making these mixtures a viable strategy for developing new antibiotic treatments. Jens Rolff of the Freie Universitat Berlin, Germany, and colleagues report these findings in a new study publishing July 2nd in the open-access journal PLOS Biology.
Antibiotic-resistant bacteria have become a major threat to public health. The World Health Organization estimates ...
2024-07-02
The Mediterranean Diet is a powerful ally for health even after a cancer diagnosis. This is the key result of an Italian study carried out as part of the UMBERTO Project, conducted by the Joint Research Platform Umberto Veronesi Foundation - Department of Epidemiology and Prevention of the I.R.C.C.S. Neuromed of Pozzilli, in collaboration with the LUM "Giuseppe Degennaro" University of Casamassima (BA). According to this research, people diagnosed with any type of tumor, who had a high adherence to the Mediterranean Diet in the year preceding their enrollment into the study, live longer and have a reduced risk of cardiovascular mortality, ...
2024-07-02
The International Biogeography Society (TIBS) has relaunched its flagship open-access scientific journal, Frontiers of Biogeography (FoB), on the ARPHA platform, where it will be co-published with Pensoft Publishers.
This collaboration underscores the society’s commitment to maintaining high-quality, high-visibility and low-cost open-access publishing for the biogeographical community.
"This switch of our journal to a cutting-edge platform, and its committed team of editors, should continue to raise the journal's ...
2024-07-02
BINGHAMTON, N.Y. -- National Science Foundation (NSF) officials joined Binghamton University, State University of New York to officially launch the Upstate New York Energy Storage Engine. After winning the designation earlier this year, Binghamton University and its New Energy New York and Engine coalition partners gathered to celebrate what this all means to the region.
At a press conference on Thursday, Binghamton University President Harvey Stenger welcomed NSF Assistant Director of the Technology, Innovation and Partnerships (TIP) Directorate Erwin Gianchandani to Binghamton to help launch the Engine program.
Erwin ...
2024-07-02
In 2023, the American Library Association documented hundreds of attempts to remove more than 4,000 books from schools and libraries across nearly all states in the U.S.
In one of the first comprehensive analyses of book bans in the U.S., a University of Colorado Boulder researcher and her collaborators revealed that these bans disproportionally target women authors of color, and a large portion of the banned books feature characters of color.
The findings appeared June 11 in the journal ...
2024-07-02
The American Society for Nutrition (ASN) has announced that next year’s meeting is scheduled to be held May 31 – June 3, 2025, in Orlando, Florida. NUTRITION is the premier meeting for the nutrition community, exploring developments in clinical and translational nutrition, food science and systems, diet and disease, basic science, global health and more. In its seventh year, the event has continued to evolve and grow with innovative scientific sessions and networking opportunities for scientists, clinicians and healthcare professionals interested in ...
2024-07-02
MADISON — A promising therapy that treats blood cancers by harnessing the power of the immune system to target and destroy cancer cells could now treat solid tumors more efficiently. Thanks to a recent study published in Molecular Therapy – Methods & Clinical Development from Dan Cappabianca and Krishanu Saha at the Wisconsin Institute for Discovery, Chimeric Antigen Receptor (CAR) T-cell therapy can be improved by altering the conditions the T cells are grown in. And it was all discovered by chance.
...
2024-07-02
OKLAHOMA CITY, OKLA. – A study published today by a University of Oklahoma researcher shows that financial incentives can make a big difference in helping smokers quit. The study found that when people with low socioeconomic staus are offered small financial incentives to stop smoking (in addition to receiving counseling and pharmacotherapy, primarily nicotine replacement therapy), they achieve higher quit rates, with some measures doubling the quit rates, when compared to study participants who received the same treatments without incentives. This finding is particularly important because adults with socioeconomic challanges ...
LAST 30 PRESS RELEASES:
[Press-News.org] Editorial: Genomics has more to reveal
